サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420177

欧州の内皮機能不全市場、2028年までの予測 - 地域別分析：原因別、検査タイプ別、エンドユーザー別

Europe Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 122 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
欧州の内皮機能不全市場、2028年までの予測 - 地域別分析：原因別、検査タイプ別、エンドユーザー別
出版日: 2023年12月04日
発行: The Insight Partners
ページ情報: 英文 122 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の内皮機能不全市場は、2022年の6億1,128万米ドルから2028年には7億7,637万米ドルに成長すると予測されています。2022年から2028年までのCAGRは4.1%と推定されます。

高コレステロール、糖尿病、肥満の増加が、欧州の内皮機能不全市場を後押し

ライフスタイルの変化により、糖尿病、高血圧、脂質異常症、肥満の罹患率が上昇し、内皮機能不全の可能性が高まっています。しかし、これらは積極的なモニタリング、早期診断、身体活動によって予防することができます。メタボリックシンドロームは、CAD、糖尿病、高血圧、その他の深刻な健康問題のリスクを高める疾患群です。2型糖尿病はすでに公衆衛生上の大きな問題となっており、肥満と関連する子供や若年成人の間でますます増加しています。世界保健機関（WHO）によると、2019年には糖尿病が150万人の死亡の直接の原因となり、糖尿病による死亡の48％は70歳までに起きています。また、腎臓病による46万人の死亡も糖尿病が原因です。血糖値の上昇は心血管系死亡の～20％を引き起こします。

高血圧は、世界の心血管疾患と早死の主な原因です。インペリアル・カレッジ・ロンドンとWHOが主導した、人口における高血圧の有病率、発見、治療、コントロールの動向に関する初の包括的な世界的分析によると、30～79歳の成人の高血圧患者数は、過去30年間で6億5,000万人から12億8,000万人に増加しています。

欧州の内皮機能不全市場概要

欧州の内皮機能不全市場は、英国、ドイツ、イタリア、フランス、スペイン、その他欧州に細分化されます。心血管疾患の有病率の上昇、高齢化人口の増加、研究開発活動の活発化が、同地域の市場成長に寄与する主な要因です。さらに、製品の発売と政府投資は、予測期間中の市場成長を促進すると思われます。

欧州の内皮機能不全市場の収益と2028年までの予測（金額）

欧州の内皮機能不全市場のセグメンテーション

欧州の内皮機能不全市場は、原因、検査タイプ、エンドユーザー、国別に細分化されます。

原因別では、欧州の内皮機能不全市場は、高血圧、高コレステロール血症、肥満、糖尿病、ベーチェット病、その他に区分されます。2022年の欧州の内皮機能不全の市場シェアは、高血圧セグメントが最大を記録しました。

検査タイプに基づき、欧州の内皮機能不全市場は侵襲的検査と非侵襲的検査に区分されます。侵襲的検査セグメントが2022年の欧州の内皮機能不全市場シェアでより大きな割合を占めています。非侵襲的検査セグメントはさらに、血流依存性血管拡張反応、末梢動脈トノメトリー（PAT）、静脈閉塞プレチスモグラフィー、循環マーカー、その他に細分化されます。

エンドユーザーに基づくと、欧州の内皮機能不全市場は病院、診断センター、クリニック、その他に分類されます。病院セグメントが2022年の欧州の内皮機能不全市場で最大のシェアを占めています。

国別では、欧州の内皮機能不全市場は、英国、ドイツ、イタリア、フランス、スペイン、その他欧州に区分されます。2022年の欧州の内皮機能不全市場はドイツが独占。

ZOLL Medical Corp、Sphingo Tec GmbH、The Polymath Co、SMART Medical Ltd、Alam Medical SaRl、Medizinische Messtechnik GmbHは、同地域の内皮機能不全市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 欧州の内皮機能不全市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の内皮機能不全市場-市場情勢

  • 概観
  • PEST分析
    • 欧州のPEST分析
  • 専門家の見解

第5章 欧州の内皮機能不全市場：主要市場力学

  • 市場促進要因
    • 心血管疾患の増加
    • 高コレステロール、糖尿病、肥満の増加
  • 市場抑制要因
    • 内皮機能不全のスクリーニング技術に伴う欠点
  • 市場機会
    • 新規バイオマーカーと治療戦略の利用増加
  • 今後の動向
    • 内皮機能不全を評価するための非侵襲的方法の使用
  • 影響分析

第6章 内皮機能不全市場：欧州分析

  • 欧州の内皮機能不全市場の収益予測と分析

第7章 欧州の内皮機能不全市場分析：原因別

  • 欧州の内皮機能不全市場：原因別、2022年・2028年（%）
  • 高血圧
  • 糖尿病
  • 高コレステロール血症
  • ベーチェット病
  • 肥満症
  • その他

第8章 欧州の内皮機能不全市場分析：検査タイプ別

  • 欧州の内皮機能不全市場：検査タイプ別、2022年・2028年（%）
  • 侵襲的検査
  • 非侵襲的検査

第9章 欧州の内皮機能不全市場分析：エンドユーザー別

  • 欧州の内皮機能不全市場：エンドユーザー別、2022年・2028年（%）
  • 病院
  • 診断センター
  • クリニック
  • その他

第10章 欧州の内皮機能不全市場-収益と2028年までの予測：国別分析

  • 欧州

第11章 欧州の内皮機能不全市場-業界情勢

  • 内皮機能不全市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • The Polymath Co
  • SMART Medical Ltd
  • Alam Medical SaRl
  • Medizinische Messtechnik GmbH

第13章 付録

図表

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. Germany Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. UK Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. UK Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. UK Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. UK Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. France Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. France Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. France Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. France Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Italy Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Italy Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Italy Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Italy Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Spain Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Spain Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Spain Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Spain Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Rest of Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Rest of Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Rest of Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 29. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. Europe Endothelial Dysfunction Market Segmentation
  • Figure 2. Europe Endothelial Dysfunction Market, by Country
  • Figure 3. Europe Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in Europe Endothelial Dysfunction Market
  • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. Europe Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Europe Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Europe Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Europe: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. UK: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. France: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Growth Strategies in the Endothelial Dysfunction Market
目次
Product Code: BMIRE00029139

The Europe endothelial dysfunction market is expected to grow from US$ 611.28 million in 2022 to US$ 776.37 million by 2028. It is estimated to grow at a CAGR of 4.1% from 2022 to 2028.

Rising Incidences of High Cholesterol, Diabetes and Obesity Fuels Europe Endothelial Dysfunction Market

Lifestyle changes lead to a rise in the incidences of diabetes, hypertension, dyslipidemia, and obesity, increasing the chances of endothelial dysfunction. However, these can be prevented through proactive monitoring, early diagnosis, and physical activity. Metabolic syndrome is a group of disorders that increases the risk of CAD, diabetes, high blood pressure, and other serious health problems. Type 2 diabetes is already a major public health problem and is increasingly rising among the children and young adults associated with obesity. According to the World Health Organization (WHO), diabetes was the direct cause of 1.5 million deaths in 2019, and 48% of all deaths from diabetes occurred before age 70. Another 460,000 deaths from kidney disease were caused by diabetes. Elevated blood sugar causes ~20% of cardiovascular deaths.

Hypertension is the leading cause of cardiovascular disease and premature death worldwide. The number of adults aged 30-79 with hypertension has increased from 650 million to 1.28 billion over the past 30 years, according to the first comprehensive global analysis of trends in the prevalence, detection, treatment, and control of hypertension among the population, headed by Imperial College London and WHO.

Europe Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Europe is sub-segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. The rising prevalence of cardiovascular diseases, an increase in the aging population, and a growing number of research and development activities are the key factors contributing to the market growth in the region. Further, product launches and government investments would facilitate the market growth during the forecast period.

Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Europe Endothelial Dysfunction Market Segmentation

The Europe endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Europe endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest Europe endothelial dysfunction market share in 2022.

Based on test type, the Europe endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Europe endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Europe endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Europe endothelial dysfunction market share in 2022.

Based on country, the Europe endothelial dysfunction market is segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. Germany dominated the Europe endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, The Polymath Co, SMART Medical Ltd, Alam Medical SaRl, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Endothelial Dysfunction Market - by Cause
    • 1.3.2 Europe Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Europe Endothelial Dysfunction Market - by End User
    • 1.3.4 Europe Endothelial Dysfunction Market - by Country

2. Europe Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Expert Opinion

5. Europe Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Europe Analysis

  • 6.1 Europe Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Europe Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Europe Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Europe Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Europe Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Europe: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Europe Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sphingo Tec GmbH
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 The Polymath Co
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 SMART Medical Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Alam Medical SaRl
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medizinische Messtechnik GmbH
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms